GSTM1 and epilepsy: A retrospective study in Japanese patients with epilepsy implicated the GSTM1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity, whereas the EPHX1 polymorphisms did not lead to any elevation of transaminases in 192 Japanese patients treated with carbamazepine [88].